North america crispr and cas genes market accounted for the largest market share globally of 41.36% in 2024 The global crispr technology market was valued at approximately usd 3.6 billion in 2024 and is projected to reach nearly usd 15.2 billion by 2034, registering a cagr of 15.2% over the forecast period. The crispr and cas genes market in the u.s
The market is witnessing growing integration of crispr in drug discovery, functional genomics, and diagnostic development Download a free sample report to explore data scope, segmentation, table of content and analysis before you make a decision Regulatory support and collaborations among research entities are further driving innovation.
By application, biomedical applications held 56.43% of the crispr technology market size in 2024 and environmental & synthetic biology is set to expand at a 22.31% cagr through 2030. By product type, the crispr services segment is expected to grow at the fastest cagr in the market during the forecast period By application, the biomedical research & functional genomics segment led the market with the largest revenue share of approximately 46% in 2024. Pharmaceutical and biopharmaceutical companies lead crispr technology adoption with a 42% market share in 2023
They leverage crispr for drug discovery, target identification, and preclinical research, expediting innovative therapeutics. Market growth in the asia pacific can be attributed to the increased pharmaceutical and biotechnology investments and the rising demand for personalized medicine A surge in academic collaborations and clinical research activities in areas such as personalized medicines is fueling market growth.
